These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9110073

  • 1. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice.
    Chen P, Bauer G, Mitchell J, Factor R, Markham R, Schwartz DH.
    AIDS; 1997 Jan; 11(1):33-41. PubMed ID: 9110073
    [Abstract] [Full Text] [Related]

  • 2. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.
    Raju PA, Herzenberg LA, Herzenberg LA, Roederer M.
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):961-7. PubMed ID: 7811547
    [Abstract] [Full Text] [Related]

  • 3. L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes.
    Ho WZ, Starr SE, Sison A, Douglas SD.
    Clin Diagn Lab Immunol; 1997 May; 4(3):352-7. PubMed ID: 9144376
    [Abstract] [Full Text] [Related]

  • 4. Effects of glutathione precursors on human immunodeficiency virus replication.
    Simon G, Moog C, Obert G.
    Chem Biol Interact; 1994 Jun; 91(2-3):217-24. PubMed ID: 8194136
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and in vitro anti-HIV activity in human monocyte-derived macrophages of 2-oxothiazolidine-4(R)-carboxylic acid derivatives.
    Oiry J, Puy JY, Mialocq P, Clayette P, Fretier P, Jaccard P, Dereuddre-Bosquet N, Dormont D, Imbach JL.
    J Med Chem; 1999 Nov 18; 42(23):4733-40. PubMed ID: 10579837
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines.
    Pani A, Marongiu ME, La Colla P.
    Antiviral Res; 1993 Sep 18; 22(1):31-43. PubMed ID: 8250542
    [Abstract] [Full Text] [Related]

  • 9. A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus.
    Barditch-Crovo P, Noe D, Skowron G, Lederman M, Kalayjian RC, Borum P, Buier R, Rowe WB, Goldberg D, Lietman P.
    J Clin Pharmacol; 1998 Apr 18; 38(4):357-63. PubMed ID: 9590463
    [Abstract] [Full Text] [Related]

  • 10. Suppression of HIV-1 infection in linomide-treated SCID-hu-PBL mice.
    del Real G, Llorente M, Boscá L, Hortelano S, Serrano A, Lucas P, Gómez L, Torán JL, Redondo C, Martínez C.
    AIDS; 1998 May 28; 12(8):865-72. PubMed ID: 9631139
    [Abstract] [Full Text] [Related]

  • 11. L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain.
    Lederman MM, Georges D, Dando S, Schmelzer R, Averill L, Goldberg D.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb 01; 8(2):107-15. PubMed ID: 7834394
    [Abstract] [Full Text] [Related]

  • 12. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
    Bahr GM, Darcissac EC, Castéran N, Amiel C, Cocude C, Truong MJ, Dewulf J, Capron A, Mouton Y.
    J Virol; 2001 Aug 01; 75(15):6941-52. PubMed ID: 11435574
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC, Choi BS, Kim KC, Park KH, Lee HJ, Cho YK, Kim SI, Kim SS, Oh YK, Kim YB.
    AIDS Res Hum Retroviruses; 2016 Feb 01; 32(2):194-202. PubMed ID: 26564392
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD.
    J Exp Med; 1995 Apr 01; 181(4):1493-505. PubMed ID: 7699332
    [Abstract] [Full Text] [Related]

  • 17. Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation.
    Borghi MO, Panzeri P, Shattock R, Sozzani S, Dobrina A, Meroni PL.
    Clin Exp Immunol; 2000 Apr 01; 120(1):93-100. PubMed ID: 10759769
    [Abstract] [Full Text] [Related]

  • 18. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
    Terrill JR, Boyatzis A, Grounds MD, Arthur PG.
    Int J Biochem Cell Biol; 2013 Sep 01; 45(9):2097-108. PubMed ID: 23892094
    [Abstract] [Full Text] [Related]

  • 19. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.
    Peterson PK, Gekker G, Chao CC, Hu SX, Edelman C, Balfour HH, Verhoef J.
    J Clin Invest; 1992 Feb 01; 89(2):574-80. PubMed ID: 1310698
    [Abstract] [Full Text] [Related]

  • 20. In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
    Mengoni F, Lichtner M, Battinelli L, Marzi M, Mastroianni CM, Vullo V, Mazzanti G.
    Planta Med; 2002 Feb 01; 68(2):111-4. PubMed ID: 11859458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.